特发性帕金森病：流行病学、诊断与管理
Idiopathic Parkinson's disease: epidemiology, diagnosis and management.
作者信息
Ben-Shlomo Y, Sieradzan K
机构信息
Department of Community Health and General Practice, Trinity College, Dublin.
出版信息
Br J Gen Pract. 1995 May;45(394):261-8.
Abstract
Since the introduction of levodopa therapy for idiopathic Parkinson's disease over 20 years ago, there has been an awakening of research interest in this chronic neuro-degenerative disorder. This paper describes current understanding of the role of genetic and environmental factors in the aetiology of idiopathic Parkinson's disease and problems associated with both diagnosis and management. It briefly outlines both pharmacological and non-pharmacological options for treatment. Despite an increasing armoury of available treatments, the optimum management for this condition remains controversial.
摘要
自20多年前左旋多巴疗法被引入用于治疗特发性帕金森病以来，对这种慢性神经退行性疾病的研究兴趣开始复苏。本文阐述了目前对遗传和环境因素在特发性帕金森病病因学中的作用以及与诊断和管理相关问题的理解。它简要概述了治疗的药理学和非药理学选择。尽管可用的治疗方法越来越多，但针对这种疾病的最佳管理仍存在争议。
相似文献
1
Idiopathic Parkinson's disease: epidemiology, diagnosis and management.
Br J Gen Pract. 1995 May;45(394):261-8.
2
Parkinson's disease: aetiology, diagnosis, and management.
Hong Kong Med J. 2005 Dec;11(6):476-89.
3
Overview of Parkinson's disease.
Pharmacotherapy. 2007 Dec;27(12 Pt 2):155S-160S. doi: 10.1592/phco.27.12part2.155S.
4
[Parkinson's Disease: Clinical Review and Update].
Acta Med Port. 2019 Oct 1;32(10):661-670. doi: 10.20344/amp.11978.
5
Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.
Hosp Med. 1998 Jun;59(6):469-80.
6
Parkinson's disease. More than meets the eye.
Adv Nurse Pract. 2003 Sep;11(9):42-4, 47-8, 51 passim.
7
Examining causes and care of idiopathic parkinsonism.
Nurs Times. 1994;90(16):38-40.
8
Parkinson's disease: diagnosis and treatment.
Am Fam Physician. 2006 Dec 15;74(12):2046-54.
9
[Diagnosis and therapy of Parkinson's disease].
MMW Fortschr Med. 2005 May 17;147 Spec No 2:28-31.
10
Non-motor symptoms may herald Parkinson's disease.
Practitioner. 2009 Sep;253(1721):19-24, 2.
引用本文的文献
1
Pregabalin-associated movement disorders: A literature review.
Brain Circ. 2020 Jun 26;6(2):96-106. doi: 10.4103/bc.bc_57_19. eCollection 2020 Apr-Jun.
2
The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease.
Parkinsons Dis. 2013;2013:167843. doi: 10.1155/2013/167843. Epub 2013 Jun 11.
3
A comparison of specialist rehabilitation and care assistant support with specialist rehabilitation alone and usual care for people with Parkinson's living in the community: study protocol for a randomised controlled trial.
Trials. 2011 Nov 23;12:250. doi: 10.1186/1745-6215-12-250.
4
Genotyping Parkinson disease-associated mitochondrial polymorphisms.
Clin Med Res. 2004 May;2(2):99-106. doi: 10.3121/cmr.2.2.99.
5
Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.
Pharm Res. 2004 Aug;21(8):1313-30. doi: 10.1023/b:pham.0000036905.82914.8e.
6
Effects of community based nurses specialising in Parkinson's disease on health outcome and costs: randomised controlled trial.
BMJ. 2002 May 4;324(7345):1072-5. doi: 10.1136/bmj.324.7345.1072.
7
The effects of caring for a spouse with Parkinson's disease on social, psychological and physical well-being.
Br J Gen Pract. 1996 Sep;46(410):507-12.
8
Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.
J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):347-51. doi: 10.1136/jnnp.61.4.347.
9
How far are we in understanding the cause of Parkinson's disease?
J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):4-16. doi: 10.1136/jnnp.61.1.4.
10
Community care for patients with idiopathic Parkinson's disease.
Br J Gen Pract. 1995 May;45(394):226-7.
本文引用的文献
1
COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920.
J Chronic Dis. 1963 Sep;16:961-73. doi: 10.1016/0021-9681(63)90098-5.
2
Smoking and death rates: report on forty-four months of follow-up of 187,783 men. 2. Death rates by cause.
J Am Med Assoc. 1958 Mar 15;166(11):1294-308. doi: 10.1001/jama.1958.02990110030007.
3
Personality and cigarette smoking in Italy, Poland, and the United States.
Int J Addict. 1993 Apr;28(5):399-413. doi: 10.3109/10826089309039638.
4
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years.
Mov Disord. 1993 Apr;8(2):165-70. doi: 10.1002/mds.870080208.
5
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
Neurology. 1993 Jan;43(1):21-7. doi: 10.1212/wnl.43.1_part_1.21.
6
Treatment of Parkinson's disease.
N Engl J Med. 1993 Sep 30;329(14):1021-7. doi: 10.1056/NEJM199309303291408.
7
Patients' fall records as an aid in designing and assessing therapy in Parkinsonism.
Disabil Rehabil. 1993 Oct-Dec;15(4):189-93. doi: 10.3109/09638289309166011.
8
Environmental antecedents of young-onset Parkinson's disease.
Neurology. 1993 Jun;43(6):1150-8. doi: 10.1212/wnl.43.6.1150.
9
Drug treatment of Parkinson's disease: is "polypharmacy" best?
J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):401-3. doi: 10.1136/jnnp.57.4.401.
10
Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey.
Folia Phoniatr Logop. 1994;46(1):9-17. doi: 10.1159/000266286.
Zotero 插件